Several tumor markers for PCa have already been identified, including prostate-specific antigen (PSA); however, these can be affected by confounding factors such as benign prostatic hyperplasia (BPH), prostate gland inflammation, and prostate massage [2]. The gene discussed is KLK3; the disease is neoplasm.